Quick Takeaways
- This page summarizes Christopher Downs's Form 4 filing for CNS Pharmaceuticals, Inc. (CNSP).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 18 Apr 2023, 08:00.
Christopher Downs - 17 Apr 2023 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)
- Signature
- /s/ Christopher Downs
- Issuer symbol
- CNSP
- Transactions as of
- 17 Apr 2023
- Net transactions value
- +$9,920
- Form type
- 4
- Filing time
- 18 Apr 2023, 08:00:05 UTC
- Previous filing
- 31 Mar 2023
- Next filing
- 01 May 2023
- SEC
- View on sec.gov
Quoteable Key Fact
"Christopher Downs filed Form 4 for CNS Pharmaceuticals, Inc. (CNSP) on 18 Apr 2023."
What Changed
- Previous filing in this sequence was filed on 31 Mar 2023.
- Current net transaction value: +$9,920.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
CNSP
transaction
Common Stock
Purchase
- Transaction value
- $9,920
- Shares
- +3,100
- Change %
- +50%
- Price
- $3.20
- Shares after
- 9,251
- Date
- 17 Apr 2023
- Ownership
- Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.